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ABSTRACT 
Clinical guidelines are important tools for managing health care quality. Research on the 
origins of guidelines primarily focuses on the institutional causes of their emergence and growth. 
Individual medical researchers, however, have played important roles. This paper develops 
knowledge of the role of individual medical researchers in advancing guidelines, and of how 
researchers’ efforts were enabled or constrained by broader institutional changes. Drawing on an 
analytical case study focused on the role of Kerr White, John Wennberg, and Robert Brook, it 
shows that guidelines were a product of the interplay between institutional change in the medical 
field and actions by individual researchers, acting as institutional entrepreneurs. Increased 
government involvement in the health care field triggered the involvement of a range of new 
actors in health care. These new organizations created a context that allowed individual 
researchers to advance guidelines by creating job opportunities, providing research funding, and 
creating opportunities for researchers to engage with the policy process. Individual researchers 
availed of this context to both advance their ideas, and to draw new actors into the field. 
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Clinical guidelines have emerged as important tools for managing health care quality 
over the past forty years. Guidelines reflect the emergence of rules-based approaches to quality, 
in which the quality of care is determined by codified standards. The growing prominence of 
guidelines in the United States reflects a fundamental transformation in the institutions of 
American medicine, involving the extension of ideas from the enlightenment, which were used 
to guide work in the domain of public health since the late 19th century, to the practice of 
medicine. Prior to the rise of clinical guidelines, policy focused on standardizing medical 
training, but refrained from defining rules that could standardize physicians’ work (Stevens, 
2000). Clinical guidelines represent a reconfiguration of medical knowledge, including 
paradigms for understanding what quality health care means as well as practices for conducting 
clinical research (Lambert, 2006; Timmermans & Kolker, 2004; Weisz, Cambrosio, Keating, 
Knaapen, Schlich, & Tournay, 2007). Guidelines have impacted managerial practices and policy 
approaches to managing quality (Nigam, 2012a), status and power dynamics within the 
profession (Freidson, 1994; Menchik & Meltzer, 2010), approaches to learning among medical 
residents (Timmermans & Angell, 2001), and the roles and relationships between the medical 
profession and other powerful actors, including the state and purchasers of health insurance 
(Porter, 1995; Timmermans & Berg, 2003; Weisz et al., 2007).    
Research on the origins of guidelines largely emphasizes that they are a product of 
institutional changes in the social organization of health care. Researchers have proposed that 
members of the medical profession created guidelines in the effort to preserve professional 
authority in the face of external calls for accountability (Armstrong, 2002; Freidson, 1994), or 
that multiple actors promoted them in the effort to impose coherence and order onto a growing, 
and increasingly complex health care system (Weisz et al., 2007). A smaller body of research 
4 
 
proposes individual medical researchers played an important role in advancing guidelines—
highlighting the roles of John Wennberg, Robert Brook, and others in the United States, as well 
as Archie Cochrane and David Sackett in the United Kingdom and Canada (Gray, 1992; Gray, 
Gusmano, & Collins, 2003; Timmermans & Berg, 2003). While individuals clearly played an 
important role, the health care system is vast, complex, and notoriously difficult to change 
(Ferlie & Shortell, 2001; Lockett, Currie, Waring, Finn, & Martin, 2012). A challenge for 
research focusing on the role of individual actors is to explain how individuals are able to 
precipitate change in large and complex systems.  
This challenge of conceptualizing the roles of both individual actors and systemic factors 
in precipitating a fundamental change in American medicine echoes a broader challenge in 
organizational theory. Since the 1970s, a significant body of research in organizational theory 
has developed knowledge of effect of institutions on social action (DiMaggio & Powell, 1991; 
Meyer & Rowan, 1977; Scott, Ruef, Mendel, & Caronna, 2000). Institutions include rules that 
govern behavior, the set of actors involved in a social domain, and institutional logics—sets of 
cognitive paradigms and material practices that guide action (Scott et al., 2000). Institutions 
impact social action at the level of the organizational field—the set of interdependent actors that 
make up a distinctive social domain and share a common system of meaning, such as the health 
care system, education system, or system of organized religion (Scott, 2001; Wooten & 
Hoffman, 2008). Early work in institutional theory focused on how institutions constrained 
action by defining the cognitive frameworks that actors drew on as well as actors’ identities and 
interests (Friedland & Alford, 1991; Meyer & Rowan, 1977). Subsequently, researchers have 
increasingly examined the agency of actors in altering institutional arrangements. This shift 
toward a focus on individual agents raised the paradox of embedded agency—the challenge of 
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explaining how individual actors are able to change institutional arrangements that define and 
constrain their cognition and interests (Holm, 1995; Seo & Creed, 2002).  
To address this paradox, researchers have conceptualized the role of institutional 
entrepreneurs—actors who are embedded in an institutional environment who engage in 
deliberate action to alter institutional arrangements (DiMaggio, 1988; Hardy & Maguire, 2008; 
Lockett et al., 2012). There are two prevailing explanations of how institutional entrepreneurship 
is possible. The first explanation identifies enabling conditions for institutional entrepreneurship, 
proposing that it is more likely in emerging fields, mature fields destabilized by disruptive 
events, and fields with a multiplicity of institutional logics (Battilana, Leca, & Boxenbaum, 
2009; Hardy & Maguire, 2008). The second focuses on the characteristics of institutional 
entrepreneurs. Much of this work proposes that institutional entrepreneurs have unusual abilities 
of reflection or extraordinary political skill. A smaller body of work proposes that institutional 
entrepreneurs occupy a social position in a field that allows them to question existing 
institutional arrangements and gives them access to resources that would enable them to bring 
about change (Hardy & Maguire, 2008). Two shortcomings of these two approaches are that they 
devote limited attention to the co-evolution of organizational fields and embedded agency, and 
that they run the risk of glorifying institutional entrepreneurs as actors with preternatural powers 
of imagination or persuasive skill.  
A third approach, less developed in existing research, would conceptualize institutional 
entrepreneurship as a process. This approach would examine the dynamic relationship between 
changing field conditions and efforts by individual actors in order to conceptualize the process 
by which individual actions to transform existing institutional arrangements can emerge and 
succeed (Battilana et al., 2009; Hardy & Maguire, 2008).  
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Consistent with this third approach, I seek to understand the processes by which 
individual researchers came to advance new approaches to health care quality in American 
medicine, and by which their efforts resulted in the institutionalization of guidelines. I develop 
an analytical case study that focuses on the roles of three individuals: Kerr White, John 
Wennberg, and Robert Brook. Kerr White was one of the earliest researchers to apply 
epidemiological principles to medical research. He played a critical role in creating health 
services research as a research domain within American medicine. Health services research is a 
“multidisciplinary field of inquiry... that examines the use, costs, quality, accessibility, delivery, 
organization, financing, and outcomes of health care services” (Institute of Medicine, 1995:3). 
White helped create the context within which John Wennberg and Robert Brook were able to 
advance ideas that formed the intellectual foundations for guidelines in the 1980s and 1990s.  
I find that the institutionalization of clinical guidelines was an outcome of a recursive 
relationship between changes in field composition—the set of actors involved in an 
organizational field and the actions of institutional entrepreneurs. Growing federal government 
involvement in health care after World War II changed field composition by drawing new federal 
agencies and private organizations into the organizational field of American medicine. This shift 
in field composition created a favorable context for institutional entrepreneurship by creating job 
opportunities, sources of research funding, and access to the political process that were critical in 
allowing White, Wennberg, and Brook to advance new paradigms. White, Wennberg and Brook 
worked to further alter field composition, by drawing new actors into the organizational field. 
These new actors played a critical role in institutionalizing clinical guidelines. 
I examine the emergence and institutionalization of guidelines across three time periods. 
A setting the stage period began with growing involvement of the federal government in the 
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health care system after World War II, and persists until 1968, the year that the National Center 
for Health Services Research (NCHSR) was created as a unit within the federal government. 
This ushered in a period of mobilization in which Wennberg and Brook worked to advance 
clinical guidelines as frameworks for conceptualizing and managing quality. The mobilization 
period persists until 1989, when Congress created the Agency for Health Care Policy and 
Research (AHCPR)—later renamed the Agency for Health Care Research and Quality 
(AHRQ)—as a new federal agency, replacing NCHSR, with a specific mandate to develop 
clinical guidelines and fund health services research. This triggered a period of 
institutionalization in which clinical guidelines became established as widely accepted 
frameworks for thinking about, measuring, and managing quality.  
DATA AND METHODS 
I use case study methods (Yin, 2003), analyzing primary and secondary texts of the 
history of health services research, and of specific efforts to advance clinical guidelines to 
develop knowledge of how the interplay between organizational fields and individual researchers 
led to the growing importance of guidelines. I analyzed archived interviews with and memoirs by 
key figures in the history of health services research, including White, Wennberg, and Brook. I 
also analyzed a broad range of other primary texts, including published first-person accounts 
outlining the activities of key actors (Flook, 1969; Huntley, 1969; Roper, Winkenwerder, 
Hackbarth, & Krakauer, 1988), conference proceedings, published articles outlining new 
approaches to health care quality (Flook & Sanazaro, 1973; Iglehart, 1984), and Institute of 
Medicine (IOM) reports. Finally, I analyzed secondary histories of the field of health services 
research and the creation and histories of both AHCPR and the IOM. 
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In analyzing the primary and secondary texts, I sought to systematically identify 
examples of the effects of new or established actors in the health care system to assess the impact 
of changing field composition. I coded the texts for evidence highlighting the context for 
institutional entrepreneurship, including evidence of direct or indirect support for individuals’ 
efforts to advance clinical guidelines specifically, or to promote health services research more 
generally. I identified examples of actions that played a role in drawing new actors into the 
organizational field to develop insight into how field composition changes.  
CASE ANALYSIS 
Setting the Stage, 1944-1968 
The period after World War II was marked by growing federal involvement in the health 
care system, which facilitated the field’s expansion and increased its complexity (Starr, 1982; 
Weisz et al., 2007). Prevailing beliefs in medicine emphasized that quality could best be 
produced by well-trained professionals exercising judgment about how to treat individual 
patients (Nigam, 2012b; Timmermans & Berg, 2003).  
Field Composition. A series of laws expanded the federal government’s role in American 
medicine between World War II and the 1960s. This legislation impacted field composition by 
mandating the creation of specific agencies or organizations within the U.S. government to play 
a role in the health care system. In 1944, the federal government substantially increased the size 
of the extra-mural grant programs—funding primarily university-based medical research—of the 
National Institutes of Health (NIH), expanding its role as an actor in the health care system 
(Dunn & Jones, 2010; Starr, 1982). In 1963, the Health Professions Educational Assistance Act 
financed expansion in medical schools, facilitating growth in academic medicine (Dunn & Jones, 
2010; MacBride, 1973). In 1965, the federal government created Medicare and Medicaid, 
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offering government financing of health care for the elderly and poor, marking an unprecedented 
expansion in the federal government’s involvement in health care (Starr, 1982; Stevens, 2000). 
The creation of Medicare expanded the role of the federal government’s Department of Health, 
Education, and Welfare (HEW)—since renamed the Department of Health and Human Services 
(HHS)—in the healthcare field. In the same year, Congress created the Regional Medical 
Program (RMP) to promote rural access to the benefits of academic medicine and medical 
research. The RMP facilitated cooperative relations between medical schools, research 
institutions, and hospitals through its regional offices (U.S. Department of Health Education and 
Welfare, 1967; Wennberg, 2010).  
As part of this expansion, the federal government began to finance health services 
research. Complementing its role in financing hospital construction, Congress designated $1.2 
million for “hospital research and demonstrations” in 1955 (Berkowitz, 1998d; Flook, 1969). 
The NIH created the “hospital facilities research” study section in 1955 to administer its funds, 
which were first distributed in 1956 (McCarthy & White, 2000). Subsequent legislation 
increased federal funding for health services research through the late 1950s and early 1960s 
(Flook, 1969; McCarthy & White, 2000).  
Complementing the federal government’s direct effects on field composition—including 
the involvement of the NIH, HEW, and fifty-four offices of the RMP—the government’s 
increased role also had indirect effects on field composition. Financing of medical research and 
education promoted growth in academic medicine, including physician researchers with faculty 
positions at major medical schools and teaching hospitals (Berkowitz, 1998e; Dunn & Jones, 
2010; Starr, 1982). Growth in medical schools and in federal financing for health services 
research was accompanied by the emergence of health services research departments. The 
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federal government’s growing role in the medical field was also accompanied by increased 
funding and activity by major private foundations aimed at influencing policy (Berkowitz, 
1998e; Flook & Sanazaro, 1973; Iglehart, 1983).  
Context for Institutional Entrepreneurship. These changes in field composition helped 
create a context within which Kerr White was able to establish health services research as an area 
of research within the medical profession. Kerr White was one of the first researchers in the 
United States to use epidemiological principles to examine patterns of medical care. His work 
used epidemiological methods to look at patterns of patient care in order to develop knowledge 
of whether medical care was doing more harm than good, and whether physicians were 
responding to concerns expressed by patients. One important goal in his career was to put in 
place systems for systematically collecting data about what physicians did in caring for 
populations of patients in order to allow researchers to make empirical judgments about the 
quality of care in the system.  His work represented a sharp break from existing clinical research, 
which focused on the mechanisms of disease, and represented a challenge to prevailing beliefs 
that medical professionals consistently provided the care that benefitted patients, and that the 
quality of care could best be judged by individual physicians (Berkowitz, 1998d).  
White’s interest in using epidemiological approaches to study medicine was informed by 
the influence of Jerry Morris, head of the United Kingdom Medical Research Council’s Social 
Medicine Research Unit at the London Hospital. Morris was a pioneer in the use of 
epidemiological principals for understanding medical care in the U.K. White’s interests were 
also shaped by his involvement with an interdisciplinary group of peers at the University of 
North Carolina, where he participated in a workshop that included physician researchers, public 
health scholars, and sociologists with an interest in health and medicine (Berkowitz, 1998d).  
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While various intellectual influences shaped White’s desire to use epidemiological 
principals to examine patterns of medical care, changes in field compositions created job 
opportunities that allowed White to advance his ideas and establish a career as a health services 
researcher. After completing his training, White took his first faculty job as an assistant professor 
at the University of North Carolina (UNC) medical school in 1952. He described this job as a 
product of the expansion of medical education: 
[University of North Carolina] was a two-year school and it became a four-year school in 1952-
53; in fact it was the first new four-year school after World War II. There had been no clinical 
faculty before when it was a two-year school, so we were among the first clinical faculty there 
and it blossomed forth (Berkowitz, 1998d). 
Ongoing changes in the field created a sequence of job opportunities that allowed White 
to develop a career. In 1962, White was offered a job in a newly created department of 
Epidemiology and Community Medicine at the University of Vermont, potentially the first 
medical school department using the word epidemiology. He viewed this job as an opportunity to 
pursue his intellectual interests—using epidemiological principals for examining population-
level patterns of medical treatment. At Vermont, he attempted to put in place a system for 
collecting population-level data on physician practices, an effort that was unorthodox at the time. 
He described the opposition he faced: 
It turned out to be a much more difficult task than I had envisaged. We had quite a time. I was 
called a communist by the medical society, and I was hauled up before the trustees of the 
medical society. I talked to rooms full of lawyers, hospital boards, and administrators 
(Berkowitz, 1998d).  
Shortly after arriving in Vermont, he was offered a job as head of a newly created 
department of Public Health Administration at Johns Hopkins University, one of the most 
prestigious universities for medical and public health research in the country. Describing the 
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rationale for the new department, White said that “Medicare and Medicaid were just coming in 
and I think they hired me to give a course on how to fill out Medicare forms” (Berkowitz, 
1998d). Describing his decision to leave Vermont, White recalled: 
They offered me a substantial budget and prime real estate, originally in the hospital itself. I 
thought, "Well, you can probably say things from Hopkins that you can't say from Vermont, or 
you can say the same sort of things but your colleagues pay more attention when you come 
from Hopkins" (Berkowitz, 1998d). 
Changing field composition in American medicine also created new resources that 
allowed White to pursue his research. In 1956, while at UNC, White applied for and received a 
grant from the first batch of funds made available for “hospital facilities research” through the 
Hill-Burton Act. Through his time at UNC, he was also able to get funding from major 
foundations, including the Commonwealth Fund and the Rockefeller Foundation, to support his 
research. As head of a new department at the University of Vermont, he had a large research 
budget that he could use to do population-based studies. He also was able to get additional 
funding from the NIH.  
Finally, changing field composition created opportunities for participation in the political 
system. In 1956, a year after receiving his first NIH grant, through the Hill-Burton act, White 
was appointed to the NIH’s Hospital Facilities Study Section, the first NIH study section 
dedicated to administering funds for health services research. He later became head of a 
reorganized “health services research” study section (McCarthy & White, 2000). He used this 
avenue to help establish health services research as a field of research within medicine, and 
create the NCHSR as an organization within the federal government to coordinate and fund 
health services research. 
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Practices of Institutional Entrepreneurs. Facilitated by the changing context for 
institutional entrepreneurship, White, in addition to advancing new ideas, further changed field 
composition by helping create NCHSR. He was able to do so, in part, because of his role as a 
member of the Hospital Facilities Research study section at NIH. Together with the section’s 
executive secretary, Thomas McCarthy, he engaged in a multi-pronged effort to help establish 
health services research as a legitimate research domain. Among their efforts, they forged 
relationships with individuals representing different interest groups, including the American 
Hospital Association, the American Medical Association, and administrators in HEW. Through 
these meetings, they helped define a collective goal to work for the creation of a unit in the 
Office of the Assistant Secretary of HEW to coordinate and fund health services research 
(McCarthy & White, 2000). Given this collective goal, White recounted that a “loose coalition 
lobbied [the] Assistant Secretary of HEW and others in the federal government to get NCHSR 
established” (Berkowitz, 1998d). As an important new actor for coordinating and funding health 
services research, the NCHSR played an important role in facilitating subsequent efforts—by 
John Wennberg, Robert Brook, and others—to advance the intellectual foundations for 
guidelines.     
Mobilization, 1969-1989 
The growing federal government role in health care through the 1950s and 1960s set in 
motion processes that brought additional actors into the field in the 1970s, including the Institute 
of Medicine (IOM), the RAND Corporation, and the Health Care Financing Administration 
(HCFA). Within this context, John Wennberg and Robert Brook worked to advance ideas that 
formed the basis for guidelines development in the United States. John Wennberg published his 
research documenting geographic variations in patterns of medical treatment. He found that 
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geographic variation could not be explained by clinical factors, and that greater use of surgical 
procedures was not associated with better outcomes. Based on his findings, he concluded that 
there was limited scientific basis for much medical practice (Wennberg, 1984; Wennberg & 
Gittelsohn, 1973). Wennberg cites White and his research as a key intellectual influence, 
observing that White, a mentor, taught him “the importance of using the tools of epidemiology to 
study the health care system” (Wennberg, 2010: xi). Wennberg, like White, was also informed 
by an interdisciplinary background. In addition to his medical training, Wennberg got a degree in 
epidemiology, and enrolled in a Ph.D. program in Sociology. This interdisciplinary training 
helped motivate his early research looking at patterns of care across small areas first in Vermont, 
and later in Maine.  
Robert Brook published his work on the appropriateness of care. This research used an 
expert-defined clinical standard defining appropriate care for particular medical diagnoses to 
document the prevalence of appropriate and inappropriate care. These expert derived standards 
of appropriateness were codified rules, similar to clinical guidelines, and an important precursor 
to more evidence-based standards (Chassin, Kosecoff, Park, Winslow, Kahn, Merrick et al., 
1987). Like Wennberg, he also credits White’s intellectual influence as a mentor (Brook, 1997).   
Building on and extending an earlier generation of work in the field of health services 
research, Wennberg and Brooks’ research created an intellectual foundation for clinical 
guidelines by emphasizing a need for a better grounding of medical practice in science. Their 
efforts were enabled both by earlier changes in field composition, and by the prior efforts of Kerr 
White to establish health services research as a legitimate field of research within medicine.  
Field Composition. The growing federal government involvement in the health care 
system, combined with changes in field composition, drew additional actors into the medical 
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field. For example, the IOM was established in 1970 as an institute within the National 
Academies of Sciences. The IOM was created as a professional body of experts that would 
provide advice to the federal government and inform health policy. The IOM’s creation was 
possible because of earlier changes in field composition, including the growth in academic 
medicine, the involvement of the National Institutes of Health, and the increased involvement by 
foundations in the field. (Berkowitz, 1998e).  
The RAND Corporation’s entry into the field of American medicine was similarly 
triggered by past changes in field composition. RAND was a policy research organization that 
did contract research for the Department of Defense. Motivated by President Lyndon Johnson’s 
war on poverty, RAND became interested in adding programs focused on social policy in the 
mid-1960s. Partially in response to the creation of Medicare and Medicaid, it chose health as one 
of two social policy areas (Berkowitz, 1998a, b, c).  
Finally, the Medicare and Medicaid programs led to the creation of additional 
government agencies that played a role in the medical field. In 1972, the government created 
Professional Standards Review Organizations (PSROs) to monitor the quality and utilization of 
care by Medicare patients (Bussmann & Davidson, 1981). The PSROs were modeled on 
Experimental Medical Care Review Organizations, which were created as a pilot project funded 
by NCHSR (Salive, Mayfield, & Weissman, 1990). As Medicare and Medicaid expenditures 
continued to rise, the Secretary of HEW in the Carter Administration created the Health Care 
Financing Administration (HCFA), a unit within HEW with a specific mandate to administer 
Medicare and Medicaid. HCFA became an additional source of research funding as well as an 
important source of data (Berkowitz, 1998e; Roper et al., 1988; Santangelo, 1995).  
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Context for Institutional Entrepreneurship. This growth and increased complexity in the 
medical field created a context in which John Wennberg and Robert Brook could both develop 
careers as medical and health services researchers, and advance new ideas. Changes in field 
composition created new sources of employment for both Wennberg and Brook. Wennberg, on 
finishing his training at Hopkins, took his first job as a faculty member at the University of 
Vermont, and as the director of Vermont’s RMP. He described getting this job as the RMP 
director as a “lucky break” that gave him the resources to do his first work on geographic 
variation. (Wennberg, 2010:15). 
Brook, on finishing his training, began his career as a research fellow at NCHSR. He then 
joined the first cohort of Robert Wood Johnson Foundation clinical scholars, a fellowship 
program created to give medical researchers experience with the policy process (Altman, 1995). 
After his fellowship, he moved to RAND, where he was hired as the clinical director for the 
health insurance experiment. It was at RAND that he was able to do his initial research 
documenting the prevalence of appropriate and inappropriate care (Berkowitz, 1998b, d).  
 Changing field composition also created new sources of research funding that allowed 
Wennberg and Brook to advance their ideas. Brook’s work at the RAND corporation was funded 
by NCHSR (Berkowitz, 1998b). Wennberg recounts receiving critical funding from a number of 
sources. In addition to his budget as director of Vermont’s RMP, Wennberg received funding for 
his early work on variations, first in Vermont and later in Maine, from NCHSR, the Robert 
Wood Johnson Foundation, the Commonwealth Fund, and the Hartford Foundation (Wennberg, 
1984, 2010).  
Finally, changing field composition created new opportunities for Wennberg and Brook 
to participate in the profession and the policy process, and to publicize their ideas. Brook was 
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able to participate in the medical profession as a member of several IOM study panels, starting 
with a study section examining efforts to manage quality in Medicare (Brook, 1995; Institute of 
Medicine, 1974). The IOM and foundations similarly helped give Wennberg critical access to the 
public policy process. Wennberg credits a 1983 conference on geographic variation, combined 
with a subsequent press conference in Washington, DC, with sparking policy interest in new 
approaches to health care quality (Mullan, 2004; Wennberg, 2010). The initial conference was 
convened by the IOM with the aim of bringing research on geographic variation and 
inappropriate care to the attention of a broader audience. It was accompanied by a press 
conference, as well as a policy forum, which gave Wennberg the opportunity to form 
relationships with both members of Congress as well as key Congressional staffers. The Hartford 
Foundation further publicized the ideas discussed in the conference by underwriting a special 
issue focused on geographic variation in the journal Health Affairs, in which Wennberg outlined 
his policy proposals for addressing the problem of geographic variation (Wennberg, 1984). His 
proposals formed the basis for a number of proposed pieces of legislation between 1985 and 
1989 (Gray, 1992). The initial ties to policy audiences facilitated by the conferences and special 
issue helped guide Wennberg’s efforts to advance new paradigms. 
Practices of Institutional Entrepreneurs. Wennberg and Brook both helped draw new 
actors into the field. Both played important roles in creating the Association for Health Services 
Research (AHSR), a professional association for health services researchers, in 1981. Wennberg 
played a particularly critical role in creating the AHCPR as a new federal agency with a specific 
mandate to develop clinical guidelines. Gray (1992) underscores his role, noting "Wennberg was 
there at the beginning and the end and was the common denominator of everything that 
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happened in between. He testified at almost every relevant congressional hearing, and his name 
was invoked by almost every witness” (44).  
Wennberg deliberately cultivated ties with policy makers. In alliance with AHSR, he 
worked to lobby for increased federal financing for health services research. He met Senator 
David Durenberger through the 1983 conference on geographic variation, and cultivated 
relationships with Durenberger and his staff in the following years. In 1987, Durenberger 
sponsored legislation that funded Patient Outcomes Research Teams to develop clinical 
guidelines for specific conditions. Wennberg continued to testify before Congress and lobby for 
the creation of a new federal agency for funding health services research. These efforts 
ultimately resulted in the creation of AHCPR with a mandate to finance health services research 
and create clinical guidelines in 1989 (Gray, 1992; Mullan, 2004; Wennberg, 2010).  
Institutionalization, 1990—present 
After the creation of AHCPR, clinical guidelines became institutionalized as a central 
approach towards managing and achieving health care quality (Milgate & Hackbarth, 2005; 
Nigam, 2012b). This consolidation of the importance of clinical guidelines was a product of past 
changes in field composition which created a group of actors—including the newly created 
AHCPR—that played a collective role in advancing guidelines as new approaches to managing 
quality. The impact of HCFA’s effectiveness initiative—a program to finance research that 
would improve the quality of care for Medicare patients—illustrates. William Roper, HCFA 
administrator during the Reagan administration, announced the effectiveness initiative in an 
editorial in the New England Journal of Medicine in 1988. Drawing on Wennberg’s ideas, he 
identified “wide variations in practice patterns” as a primary motivation for embarking on the 
initiative (Roper et al., 1988). After announcing the initiative, HCFA commissioned a report 
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from the IOM to define the clinical goals and organization for the initiative (Institute of 
Medicine, 1989). At the same time, Roper joined Wennberg and AHSR in advocating for the 
creation of AHCPR to Congress and the White House (Gray, 1992; Gray et al., 2003; 
Santangelo, 1995). Concurrent with the start of the initiative and the creation of AHCPR, HCFA 
commissioned the IOM to convene a study that would identify new approaches to quality 
assurance in Medicare (Berkowitz, 1998c; Institute of Medicine, 1990, 1991; Lohr, 1995). Two 
reports from the study recommended that Medicare quality assurance could adopt principles of 
total quality management, using clinical rules, quality data, and feedback of performance 
information to physicians and hospitals to continuously improve quality of care (Institute of 
Medicine, 1990, 1991). HCFA used these findings to fund pilot projects by teams of medical and 
health services researchers. Over time, it fully embraced the findings of the IOM report, 
reorganizing the Medicare PROs as Quality Improvement Organizations in 2002 (Milgate & 
Hackbarth, 2005).  
Context for Institutional Entrepreneurship.  At this time, both Wennberg and Brook 
were well established in their careers. Wennberg had left his position at the University of 
Vermont to take a faculty position at Harvard University’s medical school. He moved to 
Dartmouth University in 1972, where he was hired as Associate Professor of Epidemiology. He 
was promoted to Full Professor in 1980. Brook remained at the RAND Corporation, where he 
became Director, and then Vice President of RAND’s health programs.  
Opportunities for Brook and Wennberg to participate in the profession and policy process 
also reflected their increased professional status and the embrace within academic medicine of 
the ideas that they advanced in their careers. There was a proliferation of IOM study panels 
dealing with issues relating to health care quality through the 1990s. Brook and his protégés were 
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regularly invited to serve on study panels. Both Brook and Wennberg were elected as members 
of the Institute of Medicine in the 1980s. In 1986, the IOM established the Gustav Lienhard 
Award to recognize career achievement in improving health care services in the United States. 
The IOM recognized Brook’s work with the Lienhard award in 2005, and Wennberg in 2008.  
DISCUSSION 
I develop an account of the process by which the interplay between institutional change 
in health care and the actions of individual medical researchers led to the emergence and 
institutionalization of clinical guidelines in American medicine. My central argument is that 
growing government involvement in American health care after World War II brought about 
changes in field composition—the set of actors involved in the health care field—by drawing 
new federal agencies, private foundations, the Rand Corporation, and the IOM into the medical 
field. These new actors created a favorable context for institutional entrepreneurship, enabling 
Kerr White, John Wennberg, and Robert Brook to advance new paradigms that led, over time, to 
the institutionalization of clinical guidelines in American medicine.  
My focus on the importance of changing field composition differs from prior research 
identifying systemic causes of the shift towards guidelines. Researchers develop two main 
arguments explaining how systemic change led to the shift towards guidelines. Freidson (1994) 
advances the first argument, proposing that escalating health care costs provoked the state and 
private purchasers of health insurance to increasingly hold medical professionals accountable for 
the cost and quality of health care. In response, elite members of the medical profession 
developed clinical guidelines as a way of demonstrating accountability and preserving 
professional authority or medical dominance. My account differs from Freidson in that it does 
not emphasize the idea that powerful actors placed new demands on the profession. Rather, it 
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focuses attention on opportunities for research created by the entry of new actors. Nor does my 
account suggest that guidelines were a product of efforts to maintain professional dominance. 
Rather it reflects the efforts of medical researchers to advance new ideas that they believe are 
important to improving quality.  
The second argument proposes that states and other actors created guidelines as tools for 
regulating an increasingly fragmented and complex system. My work is broadly consistent with 
this argument. It differs, however, in two ways. First, I highlight the role of individual 
researchers in creating an intellectual foundation for clinical guidelines. These researchers played 
a critical role in defining the professional problem—the lack of a scientific basis for medical 
practice—that could be solved through the use of guidelines. It was only after medical 
researchers defined the problem to create an intellectual foundation for guidelines that state 
agencies used them to impose order on the health care system. Second, my work focuses 
attention on specific resources—job opportunities, research funding, and opportunities for 
participating in the political process—that allowed individual medical researchers to advance 
new ideas.  
Finally, my work differs from research focused on the role of individual researchers in 
driving change. While White, Wennberg, and Brook played critical roles, as individual 
researchers, in advancing clinical guidelines, I focus attention on the role of systemic change in 
health care in making their careers possible, and in enabling their efforts to advance new 
paradigms. 
CONCLUSIONS 
My work has two broader implications for contemporary debates about embedded agency 
in organizational theory. First, distinct from prior work identifying enabling conditions for 
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institutional entrepreneurship, I show how ongoing changes in field composition—set in motion 
both by the federal government’s growing role in health care and by the efforts of institutional 
entrepreneurs—enabled and constrained efforts to advance clinical guidelines over time. This 
suggests that future work should more closely examine the dynamic relationship between 
organizational fields and embedded agency. While I focus on the importance of the changing set 
of actors in a field in enabling institutional entrepreneurship, future work could explore how 
other changing aspects of fields including the relational orientation of actors towards one another 
(Bourdieu & Wacquant, 1992), or the mix of institutional logics (Thornton & Ocasio, 2008) 
could shape the potential for embedded agency over time. Second, in focusing on the role of 
institutional entrepreneurs in drawing new actors into the medical field, my work suggests that 
future work could explore a broader range of practices of institutional entrepreneurship. 
Empirical work on institutional entrepreneurship has focused almost exclusively on their use of 
discursive practices (Battilana et al., 2009). I highlight the role of institutional entrepreneurs in 
altering field composition, a topic that has not been explored in prior work. This suggests the 
need for additional research, however, exploring other, non-discursive practices that institutional 
entrepreneurs can draw on to alter existing institutional arrangements.  
My work also has implications for our knowledge of how policy can create a context that 
supports intellectual innovation in medicine. My work provides evidence suggesting that the 
present set of policies for managing quality, including the contemporary push towards pay-for-
performance (Ryan & Blustein, 2012), is an outcome of both the expansion of the government’s 
role in health care post-World War II and the idiosyncratic paradigms advanced by individual 
institutional entrepreneurs. The emergence of health services research as an area of inquiry was 
in part an unintended outcome of federal policy choices that created relatively unconstrained 
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resources in support of medical research. Policies to expand medical education by creating new 
research oriented medical schools, or to create new funding sources for novel but loosely defined 
research areas such as “hospital facilities research,” created resources that individual researchers 
could appropriate to advance research programs that were not directly anticipated or intended by 
federal policy makers. These research paradigms were only subsequently embraced by policy 
makers.  
The Accountable Care Act is a similar expansion in the federal government’s role that, in 
addition to expanding health insurance coverage and reforming health care delivery, will likely 
create new resources that could support intellectual change in academic medicine. How the act is 
implemented, including the types of organizations created under the act and the research 
resources created through it will influence the act’s impact on the generation of new paradigms 
and ideas in medical research. My work highlights that small pools of resources to create context 
that supports novel and unanticipated ideas can have significant effects. Legislation creating the 
Center for Healthcare Innovations as part of the Accountable Care Act in the United States 
suggests that policy makers are interested in creating a context in which new ideas about health 
care delivery can be developed and flourish (Grumbach K, 2009). It is unclear that the 
implementation of health care reform under the act will be accompanied by new extra-mural or 
peer reviewed funding that could further support the development of new ideas.  Policy makers 
should be mindful of the effects that their choices in implementing major policy shifts can have 
indirect and unintended consequences on the context for intellectual innovation in medical 
research. Future work, however, is also needed to better understand how specific policies impact 
the potential for innovation in research examining how the health care delivery system can better 
achieve the goals of reduced cost and increased quality  
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